What is Psychedelic Integration?

Psychedelic Integration in my practice outside of K-AT services outlined above does not include the administration of any psychedelic medicine. However, integration is here to help you make sense of your existing experiences with psychedelics of all types (e.g. psilocybin mushrooms, MDMA, LSD, or ayahuasca).

Though psychedelic experiences take place in many contexts from clinical to spiritual or recreational, what they share in common are experiences that can be very complex, they can be helpful, but they may also bring up difficult experiences or memories (sometimes traumatic). Psychedelic integration is to help you explore and share any challenges and insights that occurred during your experience and provides support to help you process your experience and incorporate what you may have received into the conception of your self, your relationship to others, and the world at large.

Offering psychedelic integration is not an endorsement in using substances. By offering a confidential space using the principles of harm reduction, this service is a way to support people without judgment, stigma, or shame, through these experiences that may have left them with more questions than answers.

How do I access other types of Psychedelic-Assisted Therapy?

Currently, in the United States, commonly used psychedelics like psilocybin (magic mushrooms), MDMA (ecstasy), LSD (acid), and ayahuasca remain illegal outside of clinical research trial settings. Until clinical trials are completed, the only way to legally access psychedelic therapies using these substances is by participating in a clinical trial. While I do not advocate the use of illegal substances, I also understand that psychedelic medicine has been an impactful part of the human experience across cultural contexts, has been used safely, and is legal in several other countries. Most importantly, we must acknowledge that the success of this resurgence of research is owed to the history of indigenous healing practice.

Oregon Residents: Measure 109 in Oregon has created an opportunity for the legal and supervised use of psilocybin beginning in 2023 by licensed facilitators. However, this is not access to psychedelic therapy but rather access to “supported adult-use” of psilocbyin in a regulated legal environment with a trained facilitator. If this sounds confusing it’s because it is. To read further about the limitations of Measure 109 if you’re specifically looking for psychedelic therapy I recommend the following:

• When the Promises of a Policy Do Not Meet the Reality of Its Practice: Ethical Issues Within Oregon’s Measure 109

• Psychedelic Therapy Is Here. Just Don’t Call It Therapy

If you are looking specifically for a legal form of psychedelic-assisted therapy, you may be eligible to participate in a clinical trial or you can explore if Ketamine-Assisted Therapy is a fit for you with my partner clinic Synaptic Institute.